Concepedia

Keziban Ünsal-Kaçmaz

KÜ

22

Publications

3.4K

Citations

20

H-Index

2002

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of North Carolina at Chapel Hill

Pfizer (United States)

Institut Gustave Roussy

UNC Lineberger Comprehensive Cancer Center

Keziban Ünsal-Kaçmaz is an author at Bristol-Myers Squibb (United States) specializing in medicine, cell biology, and natural sciences.

Top concepts

Publications per year

2002–2023

22

Publications

22

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

Dean F. Bajorin, J. Alfred Witjes, Jürgen E. Gschwend et al. · New England Journal of Medicine · 2021 · 968 citations · Full text

Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis

Joanne R. Doherty, Chunying Yang, Kristen E.N. Scott et al. · Cancer Research · 2013 · 386 citations · Full text

, , +26

CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

Jiyeon Kim, Zeping Hu, Ling Cai et al. · Nature · 2017 · 300 citations · Full text

, , +13

Coupling of Human Circadian and Cell Cycles by the Timeless Protein

Keziban Ünsal-Kaçmaz, Thomas E. Mullen, William K. Kaufmann et al. · Molecular and Cellular Biology · 2005 · 299 citations · Full text

, , +22

The Human Tim/Tipin Complex Coordinates an Intra-S Checkpoint Response to UV That Slows Replication Fork Displacement

Keziban Ünsal-Kaçmaz, Paul D. Chastain, Ping-Ping Qu et al. · Molecular and Cellular Biology · 2007 · 235 citations · Full text

, , +17

Rows per page

1–5 of 22